Molecular Identity Structure 28-amino-acid peptide Origin Thymic peptide Research Focus Immune modulation Published Research Thymosin Alpha-1 research has focused on immune system interactions: T-cell activation: Studies show effects on T-lymphocyte maturation Dendritic cell function: Research demonstrates modulation of antigen-presenting cells Clinical use abroad: Approved in some countries (Italy, China) for hepatitis and immune-related conditions Unlike BPC-157 and TB-500, Thymosin Alpha-1 has some approved clinical applications outside the United States, providing a deeper evidence base
A small thermometer placed near your medication can prevent this expensive mistake
BPC157 & TB500 32contains 32 mg total of two synergistic peptides. 16 mg BPC-157 and 16 mg TB-500per pen. This pen is capable of dispensing precise doses of 0.25 mg, 0.5 mg, 0.75 mg, or 1 mg (delivering equal parts of each peptide per dose) for flexible administration based on research or practitioner instruction
doi: 10.1159/000085248
This compound is referenced in scientific research and is offered in multiple research formats to support a range of laboratory and study requirements
The FDA does not approve BPC 157 for human use, and its safety and efficacy have not been established through large-scale clinical trials
